Because NRG-1 has shown to be protective against cerebral and cerebrovascular injury in a number of models, elevated NRG-1 production in children with SCA may represent an endogenous response to subclinical reduced cerebral ischemia. The gene discussed is NRG1; the disease is brain ischemia.